© 2023 BioMarin. All rights reserved.
2022-04-27-BioMarin-Announces-Record-Revenues-in-First-Quarter-2022
2022-08-03-BioMarin-Announces-Record-Revenues-in-Second-Quarter-2022-Increases-Full-year-2022-Top-and-Bottom-line-Guidance
2022-10-26-BioMarin-Announces-Third-Quarter-2022-Year-over-Year-Total-Revenue-Growth-of-24-31-Excluding-KUVAN-R
2023-02-27-BioMarin-Announces-Record-Fourth-Quarter-and-Full-Year-2022-Total-Revenues-Driven-by-Strong-Global-Demand-for-VOXZOGO-R-and-Steady-Growth-of-Enzyme-Business
https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=116864128&type=PDF&symbol=BMRN&companyName=BioMarin+Pharmaceutical+Inc.&formType=10-Q&dateFiled=2022-08-04&CK=1048477
https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=117019104&type=PDF&symbol=BMRN&companyName=BioMarin+Pharmaceutical+Inc.&formType=10-Q&dateFiled=2022-10-28&CK=1048477